Intravenous tigecycline with selected multichamber bag parenteral nutrition: A compatibility study

IF 4.3 3区 材料科学 Q1 ENGINEERING, ELECTRICAL & ELECTRONIC
Katarzyna Dettlaff PhD, Julia Guzińska MSc, Pharm, Marta Klimaszewska MSc, Pharm, Katarzyna Dominiak MSc, Pharm, Anna Jelińska PhD
{"title":"Intravenous tigecycline with selected multichamber bag parenteral nutrition: A compatibility study","authors":"Katarzyna Dettlaff PhD,&nbsp;Julia Guzińska MSc, Pharm,&nbsp;Marta Klimaszewska MSc, Pharm,&nbsp;Katarzyna Dominiak MSc, Pharm,&nbsp;Anna Jelińska PhD","doi":"10.1002/jpen.2683","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Tigecycline is widely used to treat infections in intensive care units. Drugs often need to be delivered to critically ill patients feeding by parenteral nutrition (PN). Before two preparations are administered in the same infusion line, the safety of this combination should be established. The objective of this study was to determine the compatibility of tigecycline with selected multichamber bag PN (MCB-PN).</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Tigecycline was diluted in 0.9% sodium chloride solution and 5% glucose solution to obtain two 0.5 mg/ml solutions. Then the solutions were combined with selected MCB-PN in appropriate proportions. The samples were visually assessed, and pH, osmolality, turbidity, particle size, and zeta potential were measured. These measurements were made immediately after combining the solutions and after 4 h of storage at 23°C ± 1°C.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>It was determined that the pH values of the mixtures after combining with tigecycline changed by ≤0.1 unit. An increase in zeta potential was recorded, excluding one combination of tigecycline with the mixture. For all samples tested, the particle size distribution was within the acceptable range immediately after combination and after 4 h of storage. The difference in osmolality did not exceed ±3%, whereas the zeta potential decreased for only one combination. The turbidity of none of the samples exceeded a critical value.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>The physical compatibility of the tigecycline with five MCB-PN was proved. They can therefore be administered to patients in one infusion line using the Y-site.</p>\n </section>\n </div>","PeriodicalId":3,"journal":{"name":"ACS Applied Electronic Materials","volume":null,"pages":null},"PeriodicalIF":4.3000,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Electronic Materials","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jpen.2683","RegionNum":3,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, ELECTRICAL & ELECTRONIC","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Tigecycline is widely used to treat infections in intensive care units. Drugs often need to be delivered to critically ill patients feeding by parenteral nutrition (PN). Before two preparations are administered in the same infusion line, the safety of this combination should be established. The objective of this study was to determine the compatibility of tigecycline with selected multichamber bag PN (MCB-PN).

Methods

Tigecycline was diluted in 0.9% sodium chloride solution and 5% glucose solution to obtain two 0.5 mg/ml solutions. Then the solutions were combined with selected MCB-PN in appropriate proportions. The samples were visually assessed, and pH, osmolality, turbidity, particle size, and zeta potential were measured. These measurements were made immediately after combining the solutions and after 4 h of storage at 23°C ± 1°C.

Results

It was determined that the pH values of the mixtures after combining with tigecycline changed by ≤0.1 unit. An increase in zeta potential was recorded, excluding one combination of tigecycline with the mixture. For all samples tested, the particle size distribution was within the acceptable range immediately after combination and after 4 h of storage. The difference in osmolality did not exceed ±3%, whereas the zeta potential decreased for only one combination. The turbidity of none of the samples exceeded a critical value.

Conclusion

The physical compatibility of the tigecycline with five MCB-PN was proved. They can therefore be administered to patients in one infusion line using the Y-site.

静脉注射替加环素与精选多室袋肠外营养:兼容性研究
背景替加环素被广泛用于治疗重症监护病房的感染。重症患者通常需要通过肠外营养(PN)给药。在同一输液管道中使用两种制剂之前,应确定这种组合的安全性。本研究的目的是确定替加环素与选定的多室袋 PN(MCB-PN)的兼容性。方法将替加环素稀释在 0.9% 氯化钠溶液和 5% 葡萄糖溶液中,得到两种 0.5 mg/ml 的溶液。然后将这两种溶液按适当比例与选定的 MCB-PN 混合。目测样品,测量 pH 值、渗透压、浊度、粒度和 zeta 电位。结果表明,与替加环素混合后,混合物的 pH 值变化≤0.1 个单位。除了一种与替加环素混合的混合物外,ZETA电位均有所上升。所有测试样品在混合后和储存 4 小时后的粒度分布都在可接受的范围内。渗透压的差异不超过 ±3%,而只有一种组合的 zeta 电位有所下降。结论 已证明替加环素与五种 MCB-PN 具有物理兼容性。因此,它们可以通过 Y 型输液管输注给患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.20
自引率
4.30%
发文量
567
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信